The impact of the combination of baseline risk group and cytogenetic response on the survival of patients with chronic myeloid leukemia treated with interferon-α - Hasford, Joerg; Pfirrmann, M.; Shepherd, P.; Guilhot, J.; Hehlmann, Rüdiger; Mahon, F. X.; Kluin-Nelemans, H. C.; Ohnishi, K.; Steegmann, J. L.; Thaler, J. (Haematologica, the hematology journal, 2005)
Gesehen am 12.05.2022